Vizora日本語

CellSeedCellSeed Inc.7776東証グロース精密機器FY ending Dec 2025, non-consolidated, J-GAAP

CellSeed FY ending Dec 2022 results

About 92% of CellSeed's sales come from Laboratory consumables and equipment, with Cell-Sheet regenerative medicine making up much of the rest.

It lost about ¥588 for every ¥100 of sales at the operating level.

Revenue changed -21.8% from the prior year.

What changed from last year

FY ending Dec 2021 → FY ending Dec 2022

Revenue
-21.8%¥161.7M → ¥126.4M
Gross profit
-27.4%¥84M → ¥61M
Operating income
Loss-¥864.1M → -¥743.2M
Operating cash flow
Loss-¥817.2M → -¥718M

Where the money goes

FY ending Dec 2021 → FY ending Dec 2022

Where ¥100 of sales goes

For every ¥100 CellSeed sells, how much goes where, and how much is kept.

FY ending Dec 2022
Cost of sales
¥52
SG&A
¥636
Operating loss
¥588
Net loss
¥601

Annual margin trends

Gross margin48.3%
FY ending Dec 2019: 78.5%78.5%FY ending Dec 2020: 69.3%69.3%FY ending Dec 2021: 52.0%52.0%FY ending Dec 2021: 52.0%52.0%FY ending Dec 2022: 48.3%48.3%FY19FY20FY21FY21FY22
Operating margin-587.9%
FY ending Dec 2019: -283.1%-283.1%FY ending Dec 2020: -360.7%-360.7%FY ending Dec 2021: -534.8%-534.8%FY ending Dec 2021: -534.5%-534.5%FY ending Dec 2022: -587.9%-587.9%FY19FY20FY21FY21FY22
Net margin-600.9%
FY ending Dec 2019: -283.7%-283.7%FY ending Dec 2020: -393.0%-393.0%FY ending Dec 2021: -565.7%-565.7%FY ending Dec 2021: -565.7%-565.7%FY ending Dec 2022: -600.9%-600.9%FY19FY20FY21FY21FY22

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Dec 2022

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第25期(2025/01/01－2025/12/31)

    ID S100XUKD2026-03-26Open

  • EDINET (FSA Japan)

    有価証券報告書－第24期(2024/01/01－2024/12/31)

    ID S100VGWL2025-03-26Open

  • EDINET (FSA Japan)

    有価証券報告書－第23期(2023/01/01－2023/12/31)

    ID S100T4XQ2024-03-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第22期(2022/01/01－2022/12/31)

    ID S100QIL12023-03-31Open

  • EDINET (FSA Japan)

    有価証券報告書－第21期(令和3年1月1日－令和3年12月31日)

    ID S100NR3A2022-03-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第20期(令和2年1月1日－令和2年12月31日)

    ID S100L1WE2021-03-29Open

Extracted from XBRL: 41 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image